• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

As some hail new antibody treatment for Alzheimer ’s, safety and benefit questions persist
In a packed San Francisco conference room with a celebratory atmosphere, upbeat company representatives and scientists yesterday presented detailed clinical trial data on the first Alzheimer’s treatment shown to clearly, albeit modestly, slow the disease’s normal cognitive decline. The antibody therapy has buoyed a field marked by decades of failures. Now, it appears to be on the cusp of being greenlit by the U.S. Food and Drug Administration (FDA). Yet other researchers warn of potential risks, including brain swelling and brain hemorrhages that were linked to the recently disclosed deaths of two trial participants wh...
Source: Science of Aging Knowledge Environment - December 1, 2022 Category: Geriatrics Source Type: research

Humble Aspirin could cut risk of heart attack - from Guardian archive, 28 Jan 1988
Twenty-five years ago, a study claimed that heart problems could be avoided by taking tablets designed for mild pain reliefMen with outwardly healthy hearts can cut the future risk of heart attacks by 47 per cent if they take an aspirin every two days, a United States study claims today.Advance word of its publication in the New England Journal of Medicine brought warnings from specialists about the danger to stomach linings of a rush to the aspirin bottle by either sex.Work in Europe and the US over the past two years has commended aspirin as an anti-blood clotting agent for heart and stroke sufferers. Advice on dosage we...
Source: Guardian Unlimited Science - January 28, 2013 Category: Science Tags: Heart attack Pharmaceuticals industry Health guardian.co.uk Medical research Aspirin Editorial From the Guardian Source Type: news